Cargando…

Actual status of therapeutic vaccination in non-small cell lung cancer

Lung cancer is the leading cause of cancer-related death worldwide. Although treatment methods such as surgery, radiotherapy and/or chemotherapy have improved, prognosis remains unsatisfactory, and developing new therapeutic strategies is still an urgent matter. Immunotherapy is a novel therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szyszka-Barth, Katarzyna, Ramlau, Katarzyna, Goździk-Spychalska, Joanna, Spychalski, Łukasz, Bryl, Maciej, Gołda-Gocka, Iwona, Kopczyńska, Anna, Barinow-Wojewódzki, Aleksander, Ramlau, Rodryg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068811/ https://www.ncbi.nlm.nih.gov/pubmed/24966788 http://dx.doi.org/10.5114/wo.2014.42724

Ejemplares similares

Serum sCD25 Protein as a Predictor of Lack of Long-Term Benefits from Immunotherapy in Non-Small Cell Lung Cancer: A Pilot Study
por: Siemiątkowska, Anna, et al.
Publicado: (2021)

Anti-angiogenic agents in the treatment of non-small cell lung cancer
por: Szyszka-Barth, Katarzyna, et al.
Publicado: (2014)

The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients
por: Michalak, Slawomir, et al.
Publicado: (2016)

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2021)

Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab
por: Siemiątkowska, Anna, et al.
Publicado: (2023)

Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions
por: Stencel, Katarzyna, et al.
Publicado: (2021)

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients
por: Wojas-Krawczyk, Kamila, et al.
Publicado: (2013)

The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients
por: Szpechcinski, Adam, et al.
Publicado: (2019)

Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer—Clinical Trials Experience
por: Chmielewska, Izabela, et al.
Publicado: (2021)

The impact of resistance respiratory muscle training with a SpiroTiger(®) device on lung function, exercise performance, and health-related quality of life in respiratory diseases
por: Włodarczyk, Olga M., et al.
Publicado: (2015)

Current views on molecularly targeted therapy for lung cancer – a review of literature from the last five years
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2018)

Tuberculosis and diabetes mellitus – an underappreciated association
por: Skowroński, Marcin, et al.
Publicado: (2014)

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland
por: Kowalski, Dariusz M., et al.
Publicado: (2012)

Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy Individuals
por: Kufel-Grabowska, Joanna, et al.
Publicado: (2022)

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies
por: Wierzbicka, Małgorzata, et al.
Publicado: (2015)

Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions
por: Budna, Joanna, et al.
Publicado: (2018)

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
por: Bożyk, Aleksandra, et al.
Publicado: (2021)

A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
por: Sulewska, Anetta, et al.
Publicado: (2023)

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy
por: Hirsh, Vera, et al.
Publicado: (2007)

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients
por: Krawczyk, Paweł, et al.
Publicado: (2014)

The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients
por: Kucharczyk, Tomasz, et al.
Publicado: (2015)

Estimating case fatality rates of COVID-19
por: Spychalski, Piotr, et al.
Publicado: (2020)

Long-term survival in a patient with unresectable liver metastases from uveal melanoma treated with transarterial chemoembolization with irinotecan eluting beads – case report and review of literature
por: Stanisławska, Katarzyna, et al.
Publicado: (2017)

The potential therapeutic applications and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) in cancers
por: Kopczyńska, Ewa Katarzyna
Publicado: (2016)

CHANGES IN THE ANAEROBIC THRESHOLD IN AN ANNUAL CYCLE OF SPORT TRAINING OF YOUNG SOCCER PLAYERS
por: Śliwowski, R., et al.
Publicado: (2013)

Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
por: Nicoś, Marcin, et al.
Publicado: (2019)

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
por: Krawczyk, Paweł, et al.
Publicado: (2013)

Evaluation of Drug–Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor
por: Xiao, Jim J., et al.
Publicado: (2018)

Epidemiologic methods for investigating male fecundity
por: Olsen, Jørn, et al.
Publicado: (2014)

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
por: Grechko, Nikolay, et al.
Publicado: (2021)

miRNA-Seq Tissue Diagnostic Signature: A Novel Model for NSCLC Subtyping
por: Charkiewicz, Radoslaw, et al.
Publicado: (2023)

Changes of Langerhans cells during skin ageing
por: Zegarska, Barbara, et al.
Publicado: (2017)

The Skin Sensitisation of Cosmetic Ingredients: Review of Actual Regulatory Status
por: Bialas, Iwona, et al.
Publicado: (2023)

Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study
por: Winer, Eric S, et al.
Publicado: (2015)

A Signature of 14 Long Non-Coding RNAs (lncRNAs) as a Step towards Precision Diagnosis for NSCLC
por: Sulewska, Anetta, et al.
Publicado: (2022)

The Early Modern Silesian Gallows (15th–19th Century) as an Example of Stray Animals Utilization before the Rise of Institutional Veterinary Care
por: Chrószcz, Aleksander, et al.
Publicado: (2021)

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma
por: Grenda, Anna, et al.
Publicado: (2021)

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
por: Grenda, Anna, et al.
Publicado: (2021)

Maternal cigarette smoking during pregnancy and reproductive health in children: a review of epidemiological studies
por: Håkonsen, Linn Berger, et al.
Publicado: (2014)

Actual status and future directions of cardiac telerehabilitation
por: Milewski, Krzysztof, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8vdmc8knf4974qgpk9uaeida0j